Small RNAs (also referred to as small noncoding RNAs, sncRNA) are defined as polymeric
ribonucleic acid molecules that are less than 200 nucleotides in length and serve a variety of …

Abstract N 6-methyladenosine (m6A) is a eukaryotic post-transcriptional modification
involved in cell growth and developmental processes, including RNA transcription …

Cancer stem-like cells (CSC) play pivotal roles in both chemoresistance and recurrence of
many cancer types, including urothelial bladder cancer (UBC). In addition to intrinsic …

Oncolytic virotherapy holds promise for cancer treatment, but the factors determining its
oncolytic activity remain unclear. Neutrophil extracellular traps (NETs) are associated with …

As a naturally occurring cytolytic peptide, melittin (MLT) not only exhibits a potent direct
tumor cell-killing effect but also possesses various immunomodulatory functions. MLT shows …

Accumulating data show that N6-methyladenosine (m6A) methyltransferase METTL3 and
long noncoding RNA MALAT1 act pivotal roles in multiple malignancies including prostate …

Abstract N6-methyladenosine (m6A) methylation, the most prevalent and abundant RNA
modification in eukaryotes, has recently become a hot research topic. Several studies have …

Abstract Introduction N6-methyladenosine (m 6 A) modification contributes to the
pathogenesis and development of various cancers, including bladder cancer (BCa). In …

Background MicroRNAs (miRNAs) play a critical role in cancer development and
progression, the dis-regulation of miR-30c-5p has been observed in various malignant …

N6-metyladenosine (m6A), one of the most common RNA methylation modifications in
mammals, has attracted extensive attentions owing to its regulatory roles in a variety of …